Table 1. Clinical data of 106 patients.
| All patients (n = 106) | ||
|---|---|---|
| Gender | ||
| Male | 70 (66.04) | |
| Female | 36 (33.96) | |
| Age (years) | ||
| AV ± SD | 57.93 ± 9.76 | |
| ≥65 | 28 (26.42) | |
| <65 | 78 (73.58) | |
| Total RAS | ||
| Mutation | 41 (38.68) | |
| Wild | 32 (30.19) | |
| Unidentified | 33 (31.13) | |
| BRAF | ||
| Mutation | 2 (1.89) | |
| Wild | 70 (66.04) | |
| Unidentified | 34 (32.08) | |
| Tumor site | ||
| Colon | 48 (45.28) | |
| Rectum | 58 (54.72) | |
| Left colon | 82 (77.36) | |
| Right colon | 24 (22.64) | |
| Metastatic site | ||
| One | 11 (10.38) | |
| Two | 45 (42.45) | |
| Three | 50 (47.17) | |
| Number of treatment lines | ||
| Below the three lines | 4 (3.77) | |
| Three lines | 78 (73.59) | |
| More than three lines | 24 (22.64) | |
| PD-1 | ||
| Combined | 44 (41.51) | |
| Not combined | 62 (58.49) | |
| Efficacy | ||
| PD | 32 (30.19) | |
| PR | 1 (0.94) | |
| SD | 73 (68.87) | |
| Death or not | ||
| Yes | 86 (81.13) | |
| No | 20 (18.87) |
Note:
Data are shown as median (range) or n (%).